checkAd

    WL NASDAQ 100 - 500 Beiträge pro Seite

    eröffnet am 17.03.02 20:26:45 von
    neuester Beitrag 18.03.02 14:38:16 von
    Beiträge: 24
    ID: 567.207
    Aufrufe heute: 0
    Gesamt: 495
    Aktive User: 0


     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 17.03.02 20:26:45
      Beitrag Nr. 1 ()


      38-TAGE-LINIE ALS UNTERSTÜTZUNG BESTÄTIGT
      Avatar
      schrieb am 17.03.02 20:30:21
      Beitrag Nr. 2 ()


      in richtung 38-tage-linie gedreht
      umsätze leicht stärker als in abwärtsrichtung
      Avatar
      schrieb am 17.03.02 20:32:50
      Beitrag Nr. 3 ()


      aufwärtstrend in richtung 38-tage-linie
      Avatar
      schrieb am 17.03.02 20:36:02
      Beitrag Nr. 4 ()


      hält er oder hält er nicht
      Avatar
      schrieb am 17.03.02 20:38:07
      Beitrag Nr. 5 ()


      wird diese bewegung gestoppt

      Trading Spotlight

      Anzeige
      East Africa Metals
      0,1390EUR +11,20 %
      East Africa Metals: Widerstand gebrochen und neues Jahreshoch! mehr zur Aktie »
      Avatar
      schrieb am 17.03.02 20:39:26
      Beitrag Nr. 6 ()


      abwarten
      Avatar
      schrieb am 17.03.02 20:42:23
      Beitrag Nr. 7 ()


      weisse kerze nur mit halbsoviel umsatz wie die letzte schwarze kerze entstanden.
      weiterhin vorsicht
      Avatar
      schrieb am 17.03.02 20:44:25
      Beitrag Nr. 8 ()


      ich warte auf eine weiße kerze
      Avatar
      schrieb am 17.03.02 20:47:51
      Beitrag Nr. 9 ()


      letzter umsatz halbiert zum vorletzten
      bleiben die umsätze so schwach prallt sie ab
      fundamental nicht mehr i.o.
      Avatar
      schrieb am 17.03.02 20:52:17
      Beitrag Nr. 10 ()


      38-tage-linie hmhhh noch nicht bestätigt
      zweite weisse kerze abwarten
      Avatar
      schrieb am 17.03.02 20:55:17
      Beitrag Nr. 11 ()


      warten auf eine weisse kerze

      umsätze das dreifache vom vorletzten (hmh bestimmt wegen des verfallstages)
      Avatar
      schrieb am 17.03.02 20:57:25
      Beitrag Nr. 12 ()


      mal sehn ob die hält
      umsätze 3m stü weniger als beim vorletzten
      Avatar
      schrieb am 17.03.02 20:59:22
      Beitrag Nr. 13 ()


      starke unterstützung
      meine spekulation die hält !!!!!
      Avatar
      schrieb am 17.03.02 21:01:56
      Beitrag Nr. 14 ()


      umsätze ziehen an
      ich finde ein gutes zeichen
      meine spekulation sie schafft die 38-tage-linie
      Avatar
      schrieb am 17.03.02 21:05:04
      Beitrag Nr. 15 ()


      38-tage-linie hält die??
      mal sehn
      umsätze zum vorletzten leicht rückläufig
      immer ein schlechtes zeichen
      Avatar
      schrieb am 17.03.02 21:06:50
      Beitrag Nr. 16 ()


      mM nach 38-tage-linie durchbrochen!!!!

      umsätze ziehen stark an !!!!!!!!
      Avatar
      schrieb am 17.03.02 21:09:23
      Beitrag Nr. 17 ()


      weiter beoachten
      Avatar
      schrieb am 17.03.02 21:11:41
      Beitrag Nr. 18 ()
      Avatar
      schrieb am 17.03.02 21:13:29
      Beitrag Nr. 19 ()


      umsätze stark abnehmend
      Avatar
      schrieb am 17.03.02 21:14:59
      Beitrag Nr. 20 ()


      auf weisse kerze warten
      Avatar
      schrieb am 17.03.02 21:16:38
      Beitrag Nr. 21 ()
      Avatar
      schrieb am 17.03.02 21:18:05
      Beitrag Nr. 22 ()


      schöne unterstützung bestätigt
      Avatar
      schrieb am 17.03.02 21:35:44
      Beitrag Nr. 23 ()
      Bullish Investors Need Reality Check
      Sun Mar 17, 8:21 AM ET

      By Pierre Belec

      NEW YORK (Reuters) - Federal Reserve (news - web sites)
      Chairman Alan Greenspan (news - web sites), in his most exuberant
      assessment of the economy in more than a year, recently spoke the
      words that launched stocks on a rocket ride: "An economic expansion
      is already well under way."

      But some Wall Street veterans worry that the bulls may be rushing into
      a trap that could be called "Irrational Exuberance, Part 2."

      In his semiannual report to Congress this month, the Fed chief seemed
      to signal the end of what may have been one of the briefest recessions
      in history. Investors, seeking to get even after getting slammed by
      crumbling stock prices last year, put on their buying boots and waded
      back in with the type of vigor not seen since the wild days of the 1990s
      bull market.

      The Dow Jones industrial average is up nearly 5 percent for the year.
      The Standard & Poor`s 500 index has poked its head above water
      after being submerged for most of the year.

      Indeed, the market`s performance has been remarkable since the Dow
      sank to a 3-year low of 8,236 on Sept. 21 shortly after the devastating
      attacks on the United States. The Dow has zoomed nearly 30 percent,
      S&P jumped 20 percent and the technology-laced Nasdaq composite
      climbed more than 35 percent, clearly putting the key stock gauges in a
      classic bull market mode, defined as a rally of 20 percent or more from
      their lows.

      The bullish enthusiasm this week sparked Salomon Smith Barney to up
      its target for the Dow to 11,400 from 10,800 previously.

      But veteran traders say investors and Greenspan, who famously
      warned about "irrational exuberance" in the stock market in December
      1996, are both suffering from "Irrational Exuberance, Part 2." The
      old-timers say the bulls will need to come to their senses and wait for
      hard evidence that the recession is in fact over and then for corporate
      earnings to improve. A balancing act would appear to be in order.

      "The majority of commentators did not see the recession coming, didn`t
      believe it when it arrived, minimized it when they acknowledged that
      the economy indeed was in recession, and now the current wisdom is
      that there was no recession after all," says James Dines, publisher of
      the Dines Letter, and a long-time investment adviser based in
      California.

      There`s too much optimism in the market, says Dines, who believes that
      cash and gold are the safest places to park money.

      "What if we turn out to be wrong,?" he says. "You would be stuck with
      cash and that is hardly the worst fate imaginable." RUN FOR YOUR
      LIFE

      Dines bet: A major stock market sell-off that will be more bone-jarring
      than most people envision. "Our advice is to run for your life," Dines
      says.

      A case can be made that the economy is rebounding. Growth in the
      fourth-quarter gross domestic product was revised to the upside and
      workers` productivity shot up at the fastest rate in two years while
      labor costs sank.

      Unfortunately, corporate earnings went into a nosedive, posting their
      biggest drop in recent memory, thus the disconnect between economic
      optimism and the corporate earnings. The slump in corporate profits
      shows one important thing: Corporate America is selling goods but
      can`t make the profits that would normally fuel the stock market.

      Yet, investors have pumped up the price-to-earnings ratio of
      companies in the S&P to a whopping 22 times this year`s earnings,
      according to the tracking firm Thomson Financial/First Call. This is just
      below 26 times when the S&P last set a record high in March 2000.
      The norm for the P/E is 15.

      It`s fair to say that investors are still not correcting to reasonable
      expectations. Never in the history of past recessions have so many people been so bullish and stocks
      so overvalued while the economy was on shaky ground.

      Bullish investors may again be proven wrong in a big way, and the nice paper profits they amassed in
      March could evaporate just as quickly.

      The jury is still out on whether the recession is over and the expansion under way. In past recessions,
      the economy has fooled Wall Street, initially signaling a recovery that turned out to be a mirage.

      DOUBLE-DIP ANYONE?

      "A double-dip alert always bears repeating in the depths of recession," says Stephen Roach, chief
      economist for Morgan Stanley. "One of the two classic preconditions of the double-dips has already
      fallen into place -- a massive rate of (business) inventory liquidation in the fourth quarter of 2001."

      What is likely to happen is that once the stimulus from this inventory drawdown is exhausted, the
      economy will stall, and the recovery may prove to be a dead-cat bounce.

      "I think the case for a double-dip is quite compelling," Roach says. "Following on the tendency of five
      of the past six recessions, I suspect double-dip could commence by springtime."

      Talk of a full-blown recovery is meaningless until there is sustained spending by businesses, which has
      been the weak link that slam-dunked the economy into recession a year ago. And in order for
      businesses to continue to buy more stuff, sales will need to accelerate relative to inventories, which will
      bring fatter profits.

      The trend lately among businesses has been to let inventories run down and to hold back on new
      production and hiring more workers until there are clear signals of a rebound in consumption.

      News of an unexpected drop in the nation`s jobless rate in February buoyed the Street, but the
      numbers were only bullish relative to economists` low expectations.

      The dip to 5.5 percent from 5.6 percent in January was caused by one-time factors such as the
      unseasonably warm weather that boosted construction jobs and the return of laid-off automobile
      workers. Traditionally, the jobless rate increases in a recession and workers continue to get pink slips
      even as the economy recovers.

      Experts say the drop in unemployment can`t be sustained and they expect the jobless rate to increase
      to more than 6 percent by the middle of the year.

      Many companies are facing cutthroat competition and can`t raise prices.

      The only way that a lot of businesses can move their goods is through massive discounting, for
      example, Detroit`s teaser zero-interest rate on loans to buy cars. So in this kind of climate, it would be
      foolhardy to expect companies to regain their stamina any time soon.

      ACCOUNTING PROBLEMS

      Then, there`s the accounting brouhaha. The betting is that first-quarter earnings will be ugly as
      companies are forced to adjust to stricter accounting rules following the Enron Corp. mess. A lot of
      nasty problems were hidden during the boom years when the high-flyers made bad acquisitions and
      the resulting write-offs are bound to slam their results.

      Also there are massive credit problems. Moody`s Investors Service, the credit rating firm, has
      downgraded five times the number of companies that it upgraded in the first quarter.

      Investors need a reality check because the backdrop for a bull market may not be as rosy as they
      think.

      For the week, the Nasdaq fell 3.2 percent to 1,868, the Dow gained 0.3 percent to 10,607 and the
      S&P 500 rose 0.2 percent to 1,166.

      (Pierre Belec is a freelance writer who covers stocks for Reuters. Any opinions in the column are
      solely those of Mr. Belec.)
      Avatar
      schrieb am 18.03.02 14:38:16
      Beitrag Nr. 24 ()


      Heute - Andrx: Richterspruch begünstigt generisches Naprelan

      Die im US-Staat Florida ansässige Andrx Corporation (Nasdaq:ADRX) gab die positive Nachricht bekannt, Richter Adelberto Jordan vom US-Bezirksgericht des südlichen Distriktes von Florida habe in seinem abschließenden Urteil zugunsten von Andrx entschieden. Der Richter stimmte dem Unternehmen zu und erklärte das US-Patent Nr. 5,637,320, welche die Rechte der Elan Corporation an Naprelan absichert, für ungültig. Naprelan ist ein bereits vermarktetes Schmerzmedikament der Elan Corporation, das zur Behandlung von durch Arthritis, Osteoporose und anderer entzündlicher Erkrankungen hervorgerufener Schmerzzustände, zum Einsatz gelangt und durch eine kontrollierte Wirkstofffreisetzung die dauerhafte Eindämmung der Schmerzen gewährleistet. Gemäß der IMS Daten generierte das Markenprodukt Naprelan im Jahr 2001 etwa $30 Millionen. Andrx hatte den Zulassungsantrag für sein generisches bioäquivalentes Produkt in den Stärken 500 mg und 375 mg bereits im Juli 1998 und Mai 2000 gestellt. Im Juli 2001 erteilte die US-Gesundheitsbehörde Andrx die zeitweilige Zulassung, eine Zulassung könne jedoch, so die FDA, erst nach Beendigung des Patentstreites erteilt werden. Die entgültige FDA Entscheidung steht derzeit noch aus, sollte jedoch demnächst erfolgen.


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.
      WL NASDAQ 100